Unknown

Dataset Information

The optimal dose of succinylcholine for rapid sequence induction: a systematic review and meta-analysis of randomized trials.


ABSTRACT:

Background

The evidence base for the widely accepted standard regimen of succinylcholine for rapid sequence induction (1.0 mg kg- 1) remains unclear.

Methods

We performed a systematic review and meta-analysis of randomized trials comparing any succinylcholine regimen with the standard regimen (1.0 mg kg- 1) and reporting on intubating conditions and/or apnoea times. Results were expressed as absolute risk differences (ARD) for dichotomous data and mean differences (MD) for continuous data.

Results

We retrieved six trials with relevant data of 864 patients (ASA 1 or 2, aged 18-65 years, body mass index < 30 kg m- 2). Four regimens (0.3, 0.4, 0.5, 0.6 mg kg- 1) were compared with 1.0 mg kg- 1 in at least three trial

SUBMITTER: Putzu A 

PROVIDER: S-EPMC7053066 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature